부산대학교 도서관

Simple Summary: A decline in cancer diagnoses during the COVID-19 pandemic has been reported in many countries, including Belgium. Most of these reports focus on cancers with the highest incidence, while data for brain tumors are scarce. This study evaluates the impact of the COVID-19 pandemic on the incidence, treatment strategies, and observed survival of adults diagnosed with malignant brain tumors in Belgium in 2020. The results of this study, confirming a dramatic impact on incidence and survival, should be taken into account by policy makers when implementing measures during future disease outbreaks. Pathways for (neuro)-oncological care should be continued, and if necessary adapted, and physicians should pro-actively develop frameworks for shared and broadly informed decision making when capacity for care is reduced. (1) Background: This study evaluates the impact of the COVID-19 pandemic on the incidence, treatment, and survival of adults diagnosed with malignant brain tumors in Belgium in 2020. (2) Methods: We examined patients aged 20 and older with malignant brain tumors (2004–2020) from the Belgian Cancer Registry database, assessing incidence, WHO performance status, vital status, and treatment data. We compared 2020 incidence rates with projected rates and age-standardized rates to 2015–2019. The Kaplan–Meier method was used to assess observed survival (OS). (3) Results: In 2020, there was an 8% drop in age-specific incidence rates, particularly for those over 50. Incidence rates plunged by 37% in April 2020 during the first COVID-19 peak but partially recovered by July. For all malignant brain tumors together, the two-year OS decreased by four percentage points (p.p.) in 2020 and three p.p. in 2019, compared to that in 2015–2018. Fewer patients (−9 p.p.) with glioblastoma underwent surgery, and the proportion of patients not receiving surgery, radiotherapy, or systemic therapy increased by six percentage points in 2020. (4) Conclusions: The COVID-19 pandemic profoundly impacted the diagnosis, treatment strategies, and survival of brain tumor patients in Belgium during 2020. These findings should guide policymakers in future outbreak responses, emphasizing the need to maintain or adapt (neuro)-oncological care pathways and promote informed decision making when care capacity is limited. [ABSTRACT FROM AUTHOR]